Cargando…
Validation of a Brief Screening Instrument for Chemical Intolerance in a Large U.S. National Sample
Background: Chemical intolerance (CI) is characterized by multisystem symptoms triggered by low levels of exposure to xenobiotics including chemicals, foods/food additives, and drugs/medications. Prior prevalence estimates vary from 8–33% worldwide. Clinicians and researchers need a brief, practical...
Autores principales: | Palmer, Raymond F., Walker, Tatjana, Kattari, David, Rincon, Rudy, Perales, Roger B., Jaén, Carlos R., Grimes, Carl, Sundblad, Dana R., Miller, Claudia S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391803/ https://www.ncbi.nlm.nih.gov/pubmed/34444461 http://dx.doi.org/10.3390/ijerph18168714 |
Ejemplares similares
-
Does improving indoor air quality lessen symptoms associated with chemical intolerance?
por: Perales, Roger B., et al.
Publicado: (2022) -
Three questions for identifying chemically intolerant individuals in clinical and epidemiological populations: The Brief Environmental Exposure and Sensitivity Inventory (BREESI)
por: Palmer, Raymond F., et al.
Publicado: (2020) -
Instrumentation and computerization in U.S laboratories
por: Johnson, C
Publicado: (1969) -
Statin Intolerance: an Overview of US and International Guidance
por: Cheeley, Mary Katherine, et al.
Publicado: (2023) -
U.S. Truth, Racial Healing, and Transformation Funders' Briefing Program, January 19, 2021
por: Christopher, Gail C., et al.
Publicado: (2021)